28 research outputs found
The Destination
It is sometimes difficult to realize that you are making progress, especially in medical school. You fight your way through the dark woods, getting scratched by loose branches, not quite sure if your feet are pointed in the right direction. Sometimes the journey feels like the mountain is collapsing, your feet are falling under you, your fingers throb from frost bite. Yet, there are the days where you stop and see the beauty of the journey in front of you. The winter is not always a cold, barren place, it holds so much beauty and it is worth the fight to continue
The Effect of Explicit Solvent on Photodegradation of Decabromodiphenyl Ether in Toluene: Insights from Theoretical Study
Polybrominated
diphenyl ethers (PBDEs) have received special environmental
concern because of their potential toxicity to humans and wildlife
worldwide. However, their photochemical degradation mechanisms remain
largely unknown. Herein, a PCM/TD-DFT scheme (time-dependent density
functional theory combined with the polarizable continuum model) augmented
with explicit soluteāsolvent interactions is used to explore
the promotive effects of the toluene solvent on the photochemical
degradation debromination of deca-BDE (BDE209). The face-to-face ĻāĻ
interactions between penta-bromine-substituted phenyl and toluene
are investigated. The calculations indicate that the face-to-face
ĻāĻ interaction plays an important role in the
low-lying ĻāĻ* transitions of BDE209ātoluene
Ļ-stacking complex at around 300 nm in the sunlight region,
which leads to notable changes for the ĻĻ* excited states
and which promotes the breaking of the CāBr bonds. The photodegradation
reaction via an intermolecular charge-transfer excited state formed
by the electronic transition from a Ļ orbital of toluene to
a Ļ* orbital of BDE209 is found to be a dominant mechanism.
Our calculation results reveal the mechanism of how the participation
of an explicit toluene solvent molecule catalyzes the photodegradation
of BDE209 and explain the experimental results successfully. The present
study may provide helpful information for the removal of PBDE contamination
Electronic Structure Theory Study of the Microsolvated F<sup>ā</sup>(H<sub>2</sub>O) + CH<sub>3</sub>I S<sub>N</sub>2 Reaction
The potential energy profile of microhydrated
fluorine ion reaction
with methyl iodine has been characterized by extensive electronic
structure calculations. Both hydrogen-bonded F<sup>ā</sup>(H<sub>2</sub>O)---HCH<sub>2</sub>I and ionādipole F<sup>ā</sup>(H<sub>2</sub>O)---CH<sub>3</sub>I complexes are formed for the reaction
entrance and the PES in vicinity of these complexes is very flat,
which may have important implications for the reaction dynamics. The
water molecule remains on the fluorine side until the reactive system
goes to the S<sub>N</sub>2 saddle point. It can easily move to the
iodine side with little barrier, but in a nonsynchronous reaction
path after the dynamical bottleneck to the reaction, which supports
the previous prediction for microsolvated S<sub>N</sub>2 systems.
The influence of solvating water molecule on the reaction mechanism
is probed by comparing with the influence of the nonsolvated analogue
and other microsolvated S<sub>N</sub>2 systems. Taking the CCSDĀ(T)
single-point calculations based on MP2-optimized geometries as benchmark,
the DFT functionals B97-1 and B3LYP are found to better characterize
the potential energy profile for the title reaction and are recommended
as the preferred methods for the direct dynamics simulations to uncover
the dynamic behaviors
Table3_Systematic review of ethnomedicine, phytochemistry, and pharmacology of Cyperi Rhizoma.docx
Cyperi Rhizoma (CR) is the dry rhizome of Cyperus rotundus L., a Cyperaceae plant. It has a long history of clinical medication and is known as the āholy medicineā of gynecology. CR smells sweet and bitter. It has the effect of soothing the liver and relieving depression, regulating qi, regulating meridian and relieving pain. It can be used to treat liver qi stagnation, chest pain, spleen and stomach qi stagnation, hernia pain, irregular menstruation and other diseases. At present, the main chemical constituents isolated from CR are volatile oil, flavonoids and terpenes. Modern pharmacological studies have shown that CR has a wide range of pharmacological activities, including antidepressant, hypoglycemic, antioxidant, anti-inflammatory, antipyretic and analgesic effects. In this paper, the botany, traditional application, phytochemistry, pharmacological effects, processing and other aspects of CR are reviewed. At the same time, the shortcomings of current research of CR are discussed in depth, and the possible solutions are put forward in order to find a breakthrough point for future research of CR.</p
Table1_Systematic review of ethnomedicine, phytochemistry, and pharmacology of Cyperi Rhizoma.DOCX
Cyperi Rhizoma (CR) is the dry rhizome of Cyperus rotundus L., a Cyperaceae plant. It has a long history of clinical medication and is known as the āholy medicineā of gynecology. CR smells sweet and bitter. It has the effect of soothing the liver and relieving depression, regulating qi, regulating meridian and relieving pain. It can be used to treat liver qi stagnation, chest pain, spleen and stomach qi stagnation, hernia pain, irregular menstruation and other diseases. At present, the main chemical constituents isolated from CR are volatile oil, flavonoids and terpenes. Modern pharmacological studies have shown that CR has a wide range of pharmacological activities, including antidepressant, hypoglycemic, antioxidant, anti-inflammatory, antipyretic and analgesic effects. In this paper, the botany, traditional application, phytochemistry, pharmacological effects, processing and other aspects of CR are reviewed. At the same time, the shortcomings of current research of CR are discussed in depth, and the possible solutions are put forward in order to find a breakthrough point for future research of CR.</p
Table4_Systematic review of ethnomedicine, phytochemistry, and pharmacology of Cyperi Rhizoma.docx
Cyperi Rhizoma (CR) is the dry rhizome of Cyperus rotundus L., a Cyperaceae plant. It has a long history of clinical medication and is known as the āholy medicineā of gynecology. CR smells sweet and bitter. It has the effect of soothing the liver and relieving depression, regulating qi, regulating meridian and relieving pain. It can be used to treat liver qi stagnation, chest pain, spleen and stomach qi stagnation, hernia pain, irregular menstruation and other diseases. At present, the main chemical constituents isolated from CR are volatile oil, flavonoids and terpenes. Modern pharmacological studies have shown that CR has a wide range of pharmacological activities, including antidepressant, hypoglycemic, antioxidant, anti-inflammatory, antipyretic and analgesic effects. In this paper, the botany, traditional application, phytochemistry, pharmacological effects, processing and other aspects of CR are reviewed. At the same time, the shortcomings of current research of CR are discussed in depth, and the possible solutions are put forward in order to find a breakthrough point for future research of CR.</p
Table2_Systematic review of ethnomedicine, phytochemistry, and pharmacology of Cyperi Rhizoma.docx
Cyperi Rhizoma (CR) is the dry rhizome of Cyperus rotundus L., a Cyperaceae plant. It has a long history of clinical medication and is known as the āholy medicineā of gynecology. CR smells sweet and bitter. It has the effect of soothing the liver and relieving depression, regulating qi, regulating meridian and relieving pain. It can be used to treat liver qi stagnation, chest pain, spleen and stomach qi stagnation, hernia pain, irregular menstruation and other diseases. At present, the main chemical constituents isolated from CR are volatile oil, flavonoids and terpenes. Modern pharmacological studies have shown that CR has a wide range of pharmacological activities, including antidepressant, hypoglycemic, antioxidant, anti-inflammatory, antipyretic and analgesic effects. In this paper, the botany, traditional application, phytochemistry, pharmacological effects, processing and other aspects of CR are reviewed. At the same time, the shortcomings of current research of CR are discussed in depth, and the possible solutions are put forward in order to find a breakthrough point for future research of CR.</p
Theoretical Studies on F<sup>ā</sup> + NH<sub>2</sub>Cl Reaction: Nucleophilic Substitution at Neutral Nitrogen
The S<sub>N</sub>2 reactions at N
center, denoted as S<sub>N</sub>2@N, has been recognized to play a
significant role in carcinogenesis, although they are less studied
and less understood. The potential energy profile for the model reaction
of S<sub>N</sub>2@N, chloramine (NH<sub>2</sub>Cl) with fluorine anion
(F<sup>ā</sup>), has been characterized by extensive electronic
structure calculations. The back-side S<sub>N</sub>2 channel dominates
the reaction with the front-side S<sub>N</sub>2 channel becoming feasible
at higher energies. The minimum energy pathway shows a resemblance
to the well-known double-well potential model for S<sub>N</sub>2 reactions
at carbon. However, the complexes involving nitrogen on both sides
of the reaction barrier are characterized by NH---X (X = F or Cl)
hydrogen bond and possess C<sub>1</sub> symmetry, in contrast to the
more symmetric ion-dipole carbon analogues. In the F<sup>ā</sup> + NH<sub>2</sub>Cl system, the proton transfer pathway is found
to become more competitive with the S<sub>N</sub>2 pathway than in
the F<sup>ā</sup> + CH<sub>3</sub>Cl system. The calculations
reported here indicate that stationary point properties on the F<sup>ā</sup> + NH<sub>2</sub>Cl potential energy surface are slightly
perturbed by the theories employed. The MP2 and CAM-B3LYP, as well
as M06-2X and MPW1K functionals give overall best agreement with the
benchmark CCSDĀ(T)/CBS energies for the major S<sub>N</sub>2 reaction
channel, and are recommended as the preferred methods for the direct
dynamics simulations to uncover the dynamic behaviors of the title
reaction
DataSheet_1_Cost-Effectiveness of Pembrolizumab for the treatment of NonāSmall-Cell lung cancer: A systematic review.doc
IntroductionPembrolizumab, an immune checkpoint inhibitor for treating non-small cell lung cancer (NSCLC), can impose a high financial burden. Several studies have explored the cost-effectiveness of this expensive agent. We conducted a systematic review and pooled analysis to evaluate the quality of the existing pharmacoeconomic studies on pembrolizumab strategies for NSCLC treatment as well as to conclude the cost-effectiveness of such strategies.MethodsEnglish and Chinese databases were searched to collect health economic studies on pembrolizumab therapies (monotherapy or a combination with chemotherapy) compared with chemotherapy for the treatment of NSCLC patients. The reporting quality, modeling methods, and results of incremental cost-effectiveness analysis of the included literature were descriptively analyzed.ResultsA total of 24 studies, 3 in Chinese and 21 in English, were selected. All reports satisfy a median of 31 out of 40 reporting quality assessment items based on a quality checklist for pharmacoeconomic evaluations. 12 studies used the Markov model and 11 used the partitioned survival model. A common problem identified in the modeling methods was the insufficient justification of the choices of model structure and data inputs. Pembrolizumab was found to be cost-effective in the United States and Switzerland, but not in China, France, the UK, or Singapore.ConclusionThe current cost-effectiveness studies on pembrolizumab for the treatment of NSCLC are of moderate quality, and the relevant decision-analytic modeling methods have much scope for improvement. The cost-effectiveness of pembrolizumab strategies for NSCLC varies across countries, warranting the need to pay more attention to the methodologies of pharmacoeconomic research in order to produce correct outcomes in terms of cost-effectiveness for different countries.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42021250480</p